These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 33292062)
1. Identification and Characterization of Plasmin-Independent Thrombolytic Enzymes. Hassan MM; Sharmin S; Kim HJ; Hong ST Circ Res; 2021 Feb; 128(3):386-400. PubMed ID: 33292062 [TBL] [Abstract][Full Text] [Related]
2. The mouse dorsal skinfold chamber as a model for the study of thrombolysis by intravital microscopy. Boulaftali Y; Lamrani L; Rouzaud MC; Loyau S; Jandrot-Perrus M; Bouton MC; Ho-Tin-Noé B Thromb Haemost; 2012 May; 107(5):962-71. PubMed ID: 22552380 [TBL] [Abstract][Full Text] [Related]
3. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation. Singh S; Houng A; Reed GL Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005 [TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy. Collen D J Cell Biochem; 1987 Feb; 33(2):77-86. PubMed ID: 3553213 [TBL] [Abstract][Full Text] [Related]
5. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935). Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138 [TBL] [Abstract][Full Text] [Related]
7. [The fibrinolytic system and its activators]. Seifried E Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of action and thrombolytic potential of staphylokinase. Lijnen HR Verh K Acad Geneeskd Belg; 1995; 57(4):303-14. PubMed ID: 8571666 [TBL] [Abstract][Full Text] [Related]
9. The fibrinolytic system in man. Collen D; Lijnen HR Crit Rev Oncol Hematol; 1986; 4(3):249-301. PubMed ID: 2420482 [TBL] [Abstract][Full Text] [Related]
10. Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhage. Stewart D; Kong M; Novokhatny V; Jesmok G; Marder VJ Blood; 2003 Apr; 101(8):3002-7. PubMed ID: 12446443 [TBL] [Abstract][Full Text] [Related]
14. Fibrinolysis--a review. Kane KK Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587 [TBL] [Abstract][Full Text] [Related]
15. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit. Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303 [TBL] [Abstract][Full Text] [Related]
16. New approaches to thrombolytic therapy. Collen D; Lijnen HR Arteriosclerosis; 1984; 4(6):579-85. PubMed ID: 6439177 [TBL] [Abstract][Full Text] [Related]
17. Direct fibrinolytic agents: biochemical attributes, preclinical foundation and clinical potential. Marder VJ; Novokhatny V J Thromb Haemost; 2010 Mar; 8(3):433-44. PubMed ID: 19943877 [TBL] [Abstract][Full Text] [Related]
18. Real-time measurement of lysis of mural platelet deposits by fibrinolytic agents under arterial flow. Graham DA; Huang TC; Keyt BA; Alevriadou BR Ann Biomed Eng; 1998; 26(4):712-24. PubMed ID: 9662163 [TBL] [Abstract][Full Text] [Related]